| http://dbpedia.org/ontology/abstract
|
18F-FMISO or fluoromisonidazole is a radio … 18F-FMISO or fluoromisonidazole is a radiopharmaceutical used for PET imaging of hypoxia. It consists of a 2-nitroimidazole molecule labelled with the positron-emitter fluorine-18. Hypoxia is considered a negative prognostic marker for many solid tumours, and therefore an agent to detect and quantify it is highly desirable. FMISO was one of the first such agents, after initial synthesis in the late 1980s. It remains among the most popular agents for investigation of hypoxia imaging.ents for investigation of hypoxia imaging.
|
| http://dbpedia.org/ontology/casNumber
|
104613-87-8
|
| http://dbpedia.org/ontology/chemicalFormula
|
C6H818FN3O
|
| http://dbpedia.org/ontology/fdaUniiCode
|
8MSY49469G
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/18F-Fluoromisonidazole.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.ncbi.nlm.nih.gov/books/NBK23099/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
47065337
|
| http://dbpedia.org/ontology/wikiPageLength
|
12646
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1124698990
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Quantification_%28science%29 +
, http://dbpedia.org/resource/Prognosis_marker +
, http://dbpedia.org/resource/Fluorine-18 +
, http://dbpedia.org/resource/Overall_survival +
, http://dbpedia.org/resource/Chemotherapy +
, http://dbpedia.org/resource/Head_and_neck_cancer +
, http://dbpedia.org/resource/Breast_cancer +
, http://dbpedia.org/resource/Category:Nitroimidazoles +
, http://dbpedia.org/resource/Treatment_planning +
, http://dbpedia.org/resource/Category:PET_radiotracers +
, http://dbpedia.org/resource/Nitroimidazole +
, http://dbpedia.org/resource/Reduction_%28chemistry%29 +
, http://dbpedia.org/resource/Specificity_and_sensitivity +
, http://dbpedia.org/resource/Hypoxia_%28medical%29 +
, http://dbpedia.org/resource/Brain_tumour +
, http://dbpedia.org/resource/Tumour_hypoxia +
, http://dbpedia.org/resource/Oncology +
, http://dbpedia.org/resource/File:FMISO_hypoxia_accumulation_mechanism.png +
, http://dbpedia.org/resource/Radiopharmaceutical +
, http://dbpedia.org/resource/Positron_emission_tomography +
, http://dbpedia.org/resource/Nitro_compound +
, http://dbpedia.org/resource/Radiotherapy +
, http://dbpedia.org/resource/Solid_tumours +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Contrast_%28vision%29 +
, http://dbpedia.org/resource/Oxidised +
, http://dbpedia.org/resource/Diffuse +
|
| http://dbpedia.org/property/casNumber
|
104613
|
| http://dbpedia.org/property/chemicalFormula
|
C6H818FN3O
|
| http://dbpedia.org/property/chemspiderid
|
396524
|
| http://dbpedia.org/property/drugName
|
[18F]Fluoromisonidazole
|
| http://dbpedia.org/property/iupacName
|
1
|
| http://dbpedia.org/property/molecularWeight
|
188.15
|
| http://dbpedia.org/property/stdinchikey
|
HIIJZYSUEJYLMX-JZRMKITLSA-N
|
| http://dbpedia.org/property/synonyms
|
[18F]FMISO; 1H-1--2-nitroimidazole
|
| http://dbpedia.org/property/unii
|
8
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Infobox_drug +
, http://dbpedia.org/resource/Template:Cascite +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:PET_radiotracers +
, http://dbpedia.org/resource/Category:Nitroimidazoles +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/FMISO?oldid=1124698990&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/FMISO_hypoxia_accumulation_mechanism.png +
, http://commons.wikimedia.org/wiki/Special:FilePath/18F-Fluoromisonidazole.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/FMISO +
|
| http://xmlns.com/foaf/0.1/name
|
[18F]Fluoromisonidazole
|
| owl:sameAs |
http://www.wikidata.org/entity/Q21098931 +
, https://global.dbpedia.org/id/zN4V +
, http://dbpedia.org/resource/FMISO +
|
| rdf:type |
http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/ontology/Drug +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://www.wikidata.org/entity/Q8386 +
|
| rdfs:comment |
18F-FMISO or fluoromisonidazole is a radio … 18F-FMISO or fluoromisonidazole is a radiopharmaceutical used for PET imaging of hypoxia. It consists of a 2-nitroimidazole molecule labelled with the positron-emitter fluorine-18. Hypoxia is considered a negative prognostic marker for many solid tumours, and therefore an agent to detect and quantify it is highly desirable. FMISO was one of the first such agents, after initial synthesis in the late 1980s. It remains among the most popular agents for investigation of hypoxia imaging.ents for investigation of hypoxia imaging.
|
| rdfs:label |
FMISO
|
